Swedish Orphan Biovitrum - EU Taxonomy Data: Eligible & Aligned Revenues, CAPEX & OPEX

Swedish Orphan Biovitrum's EU Taxonomy Data Preview

In 2024, Swedish Orphan Biovitrum was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.

The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.

Swedish Orphan Biovitrum has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Swedish Orphan Biovitrum are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.

turnoveropexcapex

Metric (tonnes)	2025	2024	2023	2022 - 2017
Total Taxonomy Aligned A1 Turnover Portion of total company turnover generated from economic activities that are eligible under the EU Taxonomy and meet all alignment requirements, including substantial contribution, Do No Significant Harm (DNSH), and minimum safeguards.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Taxonomy Eligible A Turnover Total turnover of the company associated with activities considered eligible under the EU Taxonomy, regardless of whether they meet alignment criteria.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Non-Eligible B Turnover Total turnover of the company associated with activities that are not listed as eligible under the EU Taxonomy.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000

Metric (tonnes)	2025	2024	2023	2022 - 2017
Total Taxonomy Aligned A1 Opex Portion of total company OPEX generated from economic activities that are eligible under the EU Taxonomy and meet all alignment requirements, including substantial contribution, Do No Significant Harm (DNSH), and minimum safeguards.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Taxonomy Eligible A Opex Total OPEX of the company associated with activities considered eligible under the EU Taxonomy, regardless of whether they meet alignment criteria.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Non-Eligible B Opex Total OPEX of the company associated with activities that are not listed as eligible under the EU Taxonomy.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000

Metric (tonnes)	2025	2024	2023	2022 - 2017
Total Taxonomy Aligned A1 Capex Portion of total company CAPEX generated from economic activities that are eligible under the EU Taxonomy and meet all alignment requirements, including substantial contribution, Do No Significant Harm (DNSH), and minimum safeguards.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Taxonomy Eligible A Capex Total CAPEX of the company associated with activities considered eligible under the EU Taxonomy, regardless of whether they meet alignment criteria.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Non-Eligible B Capex Total CAPEX of the company associated with activities that are not listed as eligible under the EU Taxonomy.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Activity Level Taxonomy Aligned A1 Capex (1 activity)
6.5 CCM/CCA - Transport by motorbikes, passenger cars and light commercial vehicles 6.5 CCM/CCA - Transport by motorbikes, passenger cars and light commercial vehicles	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000

Verified Sources Behind Swedish Orphan Biovitrum’s EU Taxonomy Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Swedish Orphan Biovitrum’s data sources below and access millions more through our Disclosure Search.

a. Swedish Orphan Biovitrum's Annual Report 2024

b. Swedish Orphan Biovitrum's Annual Report 2023

c. Swedish Orphan Biovitrum's Annual Report 2022

Insights into Swedish Orphan Biovitrum's Revenues from Sustainable Activities

In 2024, Swedish Orphan Biovitrum reported EU Taxonomy-eligible revenues of SEK 10.97 billion, representing 42% of its total turnover. Of this amount, SEK 0 of Swedish Orphan Biovitrum's revenues was classified as EU Taxonomy-aligned, indicating that 0% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).^a

Insights into Swedish Orphan Biovitrum's CAPEX from Sustainable Activities

In 2024, Swedish Orphan Biovitrum reported EU Taxonomy-eligible CAPEX of SEK 381.00 million,representing 67% of its total CAPEX. Of this amount, SEK 0 of Swedish Orphan Biovitrum's CAPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).^a

Swedish Orphan Biovitrum's Taxonomy-Eligible Capex Over Time

Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex

Have Swedish Orphan Biovitrum's increased its investment in sustainable activities over time?

Since 2022, Swedish Orphan Biovitrum's taxonomy-aligned capital expenditure (CAPEX)decreased by 100%,indicating a long-term decline in green capital deployment, potentially signaling shifting priorities or reduced focus on sustainability-linked investments.^{a, c}

Insights into Swedish Orphan Biovitrum's OPEX from Sustainable Activities

In 2024, Swedish Orphan Biovitrum reported EU Taxonomy-eligible OPEX of SEK 1.24 billion,representing 35% of its total operating expenses (OPEX). Of this amount, SEK 0 of Swedish Orphan Biovitrum's OPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).^a

Welcome Back to Tracenable

Sign in to your account

Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum's EU Taxonomy Data Preview

Verified Sources Behind Swedish Orphan Biovitrum’s EU Taxonomy Data

Insights into Swedish Orphan Biovitrum's Revenues from Sustainable Activities

Insights into Swedish Orphan Biovitrum's CAPEX from Sustainable Activities

Swedish Orphan Biovitrum's Taxonomy-Eligible Capex Over Time

Have Swedish Orphan Biovitrum's increased its investment in sustainable activities over time?

Insights into Swedish Orphan Biovitrum's OPEX from Sustainable Activities

Explore Peer Companies

Humana AB

Nolato AB

Getinge AB

Elekta AB (publ)

Arjo AB (publ)

Medicover AB